For instruments traded with sufficient liquidity, a quoted market price renders a discussion about “value” unnecessary. Quoted prices are intertwined with models based on the risk-neutral valuation concept and an absence of arbitrage: Models are used to produce a price, but observed prices are also used to calibrate those models.
But what about situations where no market prices can be observed? Does an investor’s preference have an impact on the price? Can one derive a pricing model for such a case, or choose between different pricing models competing for the job? What are the assumptions about the choice of variables used by the pricing algorithm and about the dynamics of the underlying factors?
With our valuation services we have developed a setup for testing pricing and risk models that allows the detection of hidden model problems for derivatives and structured products. It can be fine tuned to reflect a firm’s short or long term hedging strategy and reveals P&L bleeding and other problems that cannot be detected by classical model validation techniques.
Model use affects the fortunes of firms in many ways, some of them unexpected. The risks can impact on the calculation of P&L movements, for example, or valuations, or the assessment of capital adequacy. There are also complex regulations – the 2011 OCC model governance guidelines. Fintegral helps clients ensure both best practice and compliance with the regulatory regime.
We subcategorise Model Risk into quantifiable and unquantifiable components.
We address the quantifiable risks with our risk quantification reports, which deploy an arsenal of methods to estimate statistical and assumption risk. Control reviews then target the unquantifiable risk by applying a standardised list of required controls based on the model’s individual elements.
To facilitate these processes Fintegral consultants have developed a control tool which automates the creation of model maps, control reviews and model risk quantifications.